Company intelligence / Profile preview

AN Venture Partners

San Francisco, California, United Statesan.vc ↗

Ownership: Private
Development stage: Other

Overview

AN Venture Partners (ANV) is a global biotech venture capital fund based in Tokyo and San Francisco. It focuses on company creation and early-stage investments in the life sciences sector, with a particular emphasis on science originating from Japan but also invests globally. The fund has strategic alliances with leading VCs such as ARCH Venture Partners and collaborates with major pharma like Shionogi. Recent investments include City Therapeutics (RNAi therapeutics) and Imbria Pharmaceuticals (cardiometabolic therapies)[1][3][4][7].

Industry: Investors

Partnerships

ARCH Venture Partners (strategic alliance)Shionogi & Co., Ltd. (strategic partner)Fast Track Initiative (alliance agreement)

Beyond the preview

Go deeper on AN Venture Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AN Venture Partners.

Explore the full profile